HysterSisters Hysterectomy Support and Information
Advertising Info HysterSisters Hysterectomy Support Tutorial

Go Back   Hysterectomy HysterSisters > Hysterectomy News Articles

HysterSisters Articles for Hysterectomy


FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs

From the Hysterectomy News Articles List

January 9, 2008

The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these mislead women and health care professionals.

The pharmacy operations improperly claim that their drugs, which contain hormones such as estrogen, progesterone, and estriol (which is not a component of an FDA-approved drug and has not been proven safe and effective for any use) are superior to FDA-approved menopausal hormone therapy drugs and prevent or treat serious diseases, including Alzheimer's disease, stroke, and various forms of cancer.

FDA is concerned that the claims for safety, effectiveness, and superiority that these pharmacy operations are making mislead patients, as well as doctors and other health care professionals. Compounded drugs are not reviewed by the FDA for safety and effectiveness, and FDA encourages patients to use FDA-approved drugs whenever possible. The warning letters state that the pharmacy operations violate federal law by making false and misleading claims about their hormone therapy drugs.

"We want to assure that Americans receive accurate information about the risks and benefits of drug therapies," said Dr. Janet Woodcock, FDA's chief medical officer and acting director of the agency's Center for Drug Evaluation and Research. "In addition to today's regulatory action, FDA is publishing an informational article for women on its consumer health information web page that provides the facts to make informed decisions about these unapproved therapies. Women taking these drugs should discuss with their health care providers the drugs' risks and whether they're getting effective treatment."

The pharmacy operations receiving warning letters use the terms "bio-identical hormone replacement therapy" and "BHRT" to imply that their drugs are natural or identical to the hormones made by the body. *FDA regards this use of "bio-identical" as a marketing term implying a benefit for the drug, for which there is no medical or scientific basis.*

The pharmacy operations also make unsupported claims that their drugs are better than FDA-approved menopausal hormone therapy drugs and can be used to prevent and treat serious diseases such as Alzheimer's disease, stroke, and various forms of cancer.

The pharmacy operations compound hormone therapy drugs that contain estriol as well as progesterone and estrogen. No drug product containing estriol has been approved by FDA and the safety and effectiveness of estriol is unknown.

Firms that do not properly address violations identified in warning letters risk further enforcement, including injunctions that prevent additional violations, and seizure of violative drugs.

FDA's action today does not target pharmacists who practice traditional pharmacy compounding and who do not make false or misleading claims about compounded products. Traditional pharmacy compounding typically involves preparation of a drug for an individual patient by a pharmacist in response to a valid prescription from a licensed practitioner. This compounding follows a practitioner's decision that his or her patient has a special medical need that cannot be met by FDA-approved drugs. FDA's current view on human drug compounding is addressed in its compounding Compliance Policy Guide, available at http://www.fda.gov/cder/pharmcomp/default.htm.

FDA also responded today to a citizen petition from Wyeth, Madison, NJ, asking FDA to take regulatory action against compounding pharmacy operations that produce compounded "BHRT" drugs.* Other stakeholders, including health care providers and consumer groups, have also raised concerns about "BHRT" drugs.

All patients who use compounded hormone therapy drugs should discuss menopausal hormone therapy options with their health care provider to determine if compounded drugs are the best option for their specific medical needs. If patients or practitioners encounter problems with compounded hormone therapy drugs, they are encouraged to file a MedWatch report with the FDA at www.fda.gov/medwatch or by phone at 1-800-FDA-1088.

For more information, see a consumer article called Bio-Identicals: Sorting Myths from Facts http://www.fda.gov/consumer/updates/...als010908.html.

Warning Letters and Q and A's are available at http://www.fda.gov/cder/pharmcomp/default.htm.

For HysterSisters Discussion of this press release: Click Here

01-09-2008 - 03:16 PM


Do you have a question?

If you have a medical support question related to this article, come JOIN US in our HysterSisters Community Forums. You will receive helpful replies to your questions from our members. See you there!

HysterSisters Free Hysterectomy Booklet

What 350,000 Women Know About Hysterectomy with pages of information, helpful tips and hints to prepare and recover from hysterectomy. Free download for members.

HysterSisters Articles

Options to Hysterectomy
Treatment Alternatives
Pre-Op Hysterectomy
Post-Op Hysterectomy
Separate Surgeries
Hormone and Menopause
Intimacy after Hysterectomy
Pelvic Floor
Separate Surgeries
Fitness after Hysterectomy
GYN Cancer
Breast Health
Grief and Loss
Uterine Fibroids
GYN Genetics
Hysterectomy Stories
Ask A Doctor

Find a Surgeon

HysterSisters Doctor Directory
Jack Ayoub, M.D.
44035 Riverside Parkway
Suite 435
Leesburg VA 20176
Clifford Rogers, M.D.
The Everett Clinic, Dept. of Surgery and Gynecology
1330 Rockefeller Ave, Suite 120
Everett WA 98201
425 339 5424
Arnold Advincula, M.D.
Columbia Ob/Gyn Midtown
51 West 51st St, 3rd FL
New York NY 10019
(855) 75-OBGYN
Stephen Zweibach, M.D.
515 S Kings Ave
Brandon FL 33511
Joseph S. Valenti, M.D.
2805 S. Mayhill Road
Denton TX 76208
940 591-6700
Theresa Holladay, M.D.
War Memorial Hospital Women’s Health
509 Osborn Blvd., Suite 120
Sault St Marie MI 49783
Geoffrey Cly, M.D.
Suite 101, 11123 Parkview Plaza Drive
Fort Wayne IN 46845
Ellen Wilson, M.D.
5323 Harry Hines Blvd - Dept of OBGYN
Dallas TX 75390
Debra Richardson, M.D.
Gynecological Oncology Clinic - SW Med
2201 Inwood Road Suite 106
Dallas TX 75390


Hysterectomy News

August 14,2020


HysterSisters Takes On Partner To Manage Continued Growth And Longevity
I have news that is wonderful and exciting! This week’s migration wasn’t a typical migration - from one set ... News Archive


Calendar - Hysterectomies - Birthdays

Request Information

I am a HysterSister


Featured Story - All Stories - Share Yours


Your Hysterectomy Date

CUSTOMIZE Your Browsing